本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中國臍帶血庫

2.99
0.0000
成交量:- -
成交額:2,792.37萬
市值:4.00億
市盈率:4.60
高:2.99
開:2.99
低:2.99
收:2.99
52周最高:2.99
52周最低:2.99
股本:1.34億
流通股本:3,563.49萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.6499
每股收益(LYR):0.6502
淨資產收益率:10.99%
總資產收益率:4.63%
市淨率:0.56
市盈率(LYR):4.59

資料載入中...

2021/06/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/24

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/24

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/06

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

SEC問詢函

[Cover]Correspondence
2019/08/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/23

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]